Safety and efficacy of tislelizumab plus chemotherapy as preoperative treatment in potentially resectable locally advanced non-small-cell lung cancer patients

OBJECTIVES Locally advanced non-small-cell lung cancer (LA-NSCLC) requires more preoperative regiments in the era of immunotherapy. Tislelizumab was approved for first-line treatment for advanced lung cancer, bringing hope for preoperative therapy in LA-NSCLC. The aim of this study was to investigat...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Interdisciplinary Cardiovascular and Thoracic Surgery 2024-01, Vol.38 (1)
Hauptverfasser:	Huang, Xuhua, Zhu, Linhai, Liu, Jiacong, Wang, Yanye, Yu, Li, Wu, Simeng, Lv, Wang, Hu, Jian
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer Chemotherapy Immunotherapy Lung cancer, Non-small cell Medical colleges Medical records Medical research Medicine, Experimental Pemetrexed Thoracic Oncology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!